Detailed Information on Publication Record
2020
Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome
ČIERNY, Marek, Sam I HOOSHMAND, Dominic FEE, Swarnendu TRIPATHI, Nikita R DSOUZA et. al.Basic information
Original name
Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome
Authors
ČIERNY, Marek, Sam I HOOSHMAND, Dominic FEE, Swarnendu TRIPATHI, Nikita R DSOUZA, Alison La Pean KIRSCHNER, Michael T ZIMMERMANN and Ryan BRENNAN
Edition
PARKINSONISM & RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2020, 1353-8020
Other information
Type of outcome
Článek v odborném periodiku
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.891
UT WoS
000578015000025
Keywords in English
Atypical parkinsonism; DCTN1; Dynactin; Genetics; Perry disease; Perry syndrome; Microtubules; Type 2 respiratory failure; Autophagy; Nocturnal hypopnea; p150(Glued); Protein stability; Predicted folding free energy; Protein modeling; Microtubule associated protein RP/EB family member 1; EB1
Změněno: 18/9/2023 21:08, MUDr. Marek Čierny
Abstract
V originále
Introduction: Perry syndrome, also recognized as Perry disease, is a rare autosomal dominant disorder characterized by midlife-onset atypical parkinsonism, apathy or depression, respiratory failure and weight loss caused by a mutation in the Dynactin (DCTN1) gene.